Freie Universität Berlin
VCP Inhibition as a Targeted Therapy for Autosomal Dominant Polycystic Kidney Disease (ADPKD): Unveiling the Role of VCP as a Ciliary Protein in ADPKD
Abstract
dc:description.abstractAutosomal dominant polycystic kidney disease (ADPKD) is a hereditary disorder characterized by progressive renal cyst development, leading to kidney enlargement and renal failure. The causative genes of ADPKD, Pkd1 and Pkd2, encode for the ciliary protein PC1 and PC2, positioning ADPKD in the ciliopathy spectrum. In this study, we investigated valosin-containing protein (VCP)'s role as a ciliary protein and its impact on ciliary assembly and morphology. In addition, we aimed to elucidate if VCP inhibition may hold therapeutic potential in specifically targeting cyst-lining cells in ADPKD. Our findings revealed that VCP colocalized with the ciliary marker ARL13B, supporting its presence in primary cilia. Prior to treatment, Pkd1-deficient cells exhibited significantly elongated primary cilia, consistent with dysregulated ciliary dynamics in ADPKD. The pharmacological inhibition of VCP (CB5083) markedly reduced the length of the elongated cilia structures found in cyst-lining cells. Furthermore, upon VCP inhibition, Pkd1-deficient cells showed a selective decrease in viability explained by upregulated UPR-mediated apoptosis. More importantly, in vivo, CB5083 treatment significantly reduced kidney-to-body-weight ratio, cystic index, and serum creatinine levels, and it also shortened cilia length. This in vivo approach demonstrates a protective effect against cystogenesis and reinforces the therapeutic potential of VCP inhibition. This study identifies VCP as a ciliary protein and points out its role in proteostasis and cystogenesis in ADPKD. The elongated cilia of Pkd1-deficient cells were significantly shortened upon VCP inhibition, suggesting an association between VCP activity and ciliary morphology. Together with the well-known role of aberrant ciliary signaling in cystogenesis, these findings support the concept that targeting cilia dynamics may represent a novel therapeutic strategy for ADPKD. Additionally, the selective induction of UPR-mediated apoptosis in Pkd1-deficient cells further underscores the potential of VCP inhibition as a targeted treatment approach.
Degree
thesis:*- Department dc:contributor.department
- Charité - Universitätsmedizin Berlin
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Pioppini, Carlotta
- Committee members dc:contributor.committeemember
-
- N.N
- N.N.
Subjects
dc:subject × 4Rights
dc:rights.accessrights- Statement dc:rights.accessrights
-
- open access
- Licence dc:rights.uri
- Language dc:language
- eng
Identifiers
dc:identifier.*- URN
- urn:nbn:de:kobv:188-refubium-52257-0
- Identifier URI
- http://dx.doi.org/10.17169/refubium-51987